Golimumab Improves Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA): 1-Year Results from a Non-Interventional Trial in Germany

被引：0

作者：

Kruger, Klaus ^{[1
]}

Remstedt, Sven ^{[2
]}

Thiele, Astrid ^{[3
]}

Klaudius, Ines ^{[4
]}

机构：

[1] Med Ctr Rheumatol, Munich, Germany

[2] Rheuma Praxis Berlin, Berlin, Germany

[3] Krankenhaus St Josef Wuppertal, Wuppertal, Germany

[4] MSD Sharp & Dohme GmbH, Haar, Germany

来源：

ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1147

引用

页数：2

共 50 条

[1] GOLIMUMAB IMPROVES WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), ANKYLOSING SPONDYLITIS (AS) AND PSORIATIC ARTHRITIS (PSA): 1-YEAR RESULTS FROM A NON-INTERVENTIONAL TRIAL IN GERMANY
Klaudius, I.
Krueger, K.
Remstedt, S.
Thiele, A.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 954 - 955
[2] Golimumab Improves Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA): Interim Results from a Non-Interventional Trial in Germany
Krueger, Klaus
Remstedt, Sven
Thiele, Astrid
Klaudius, Ines
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[3] Golimumab Improves Work Productivity and Activity and Quality of Life in Patients with Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA): Final Results from a Non-Interventional Study in Germany (GO-ART)
Krueger, Klaus
Remstedt, Sven
Thiele, Astrid
Klaudius, Ines
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[4] GOLIMUMAB IMPROVES WORK PRODUCTIVITY AND ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), ANKYLOSING SPONDYLITIS (AS) AND PSORIATIC ARTHRITIS (PSA): FINAL RESULTS FROM A NON-INTERVENTIONAL STUDY IN GERMANY (GO-ART)
Klaudius, Ines
Krueger, Klaus
Remstedt, Sven
Thiele, Astrid
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 717 - 717
[5] Golimumab in Biologic-NaiVe Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Subanalysis from a Non-Interventional Evaluation in Germany
Krueger, Klaus
Burmester, Gerd R.
Wassenberg, Siegfried
Bohl-Buehler, Martin
Thomas, Matthias H.
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[6] A NON-INTERVENTIONAL CLINICAL STUDY EVALUATING THE USE OF GOLIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA), AND ANKYLOSING SPONDYLITIS (AS) IN A REAL-LIFE SETTING IN GERMANY
Krueger, K.
Burmester, G. R.
Wassenberg, S.
Bohl-Buehler, M.
Thomas, M. H.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 232 - 232
[7] Clinical Outcomes of Golimumab As Second Line TNF Inhibitor Treatment in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Subanalysis of a Non-Interventional Study in Germany
Krueger, Klaus
Burmester, Gerd R.
Wassenberg, Siegfried
Thiele, Astrid
Thomas, Matthias H.
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[8] Golimumab Improves Patient-Reported Outcomes and Socio-and Health-Economic Parameters in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ankylosing Spondylitis (AS): Results from a Non-Interventional Clinical Evaluation in Germany
Krueger, Klaus
Burmester, G. R.
Wassenberg, Siegfried
Bohl-Buehler, Martin
Thomas, Matthias H.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[9] GOLIMUMAB AS FIRST, SECOND OR AT LEAST THIRD BIOLOGIC AGENT IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA) OR ANKYLOSING SPONDYLITIS (AS) - POST HOC ANALYSIS OF A NON-INTERVENTIONAL STUDY IN GERMANY
Krueger, Klaus
Burmester, Gerd Ruediger
Wassenberg, Siegfried
Thiele, Astrid
Thomas, Matthias
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1156 - 1157
[10] Golimumab as First, Second or at Least Third Biologic Agent in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Post Hoc Analysis of a Non-Interventional Study in Germany
Krueger, Klaus
Burmester, Gerd
Wassenberg, Siegfried
Thiele, Astrid
Thomas, Matthias
ARTHRITIS & RHEUMATOLOGY, 2019, 71

← 1 2 3 4 5 →